NEW YORK (GenomeWeb) – OneOme announced today that it has partnered with Total Quality Medicine (TQM) to offer its pharmacogenomic testing and support services in Mexico.

Under the terms of the deal, OneOme's PCR-based RightMed genetic test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be incorporated into Mexico City-based TQM's GeneTest line of personalized medicine products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.